ConductScience.org, home

Paper35778656

miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway.

Huang W and 5 others. Discov Oncol, 2022. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway. Papers, record 35778656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35778656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathway.
PubMed
Journal
Discov Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.83
iCite
Revised in PubMed
2022-07-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Huang WWei
2Zhang CCheng
3Xiong SShida
4Zhou XXiaocheng
5Wang GGongxian
6Guo JJu

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. 81860454National Natural Science Foundation of ChinaPubMed

Source PubMed

Download CSV of grants

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
124745663Bladder cancer: a portal into men's health.Urol Oncol2015https://conductscience.org/library/papers/24745663PubMed
216492744Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo.Proc Natl Acad Sci U S A2006https://conductscience.org/library/papers/16492744PubMed
328109084miR-5195-3p Inhibits Proliferation and Invasion of Human Bladder Cancer Cells by Directly Targeting Oncogene KLF5.Oncol Res2017https://conductscience.org/library/papers/28109084PubMed
421304530The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer.Br J Cancer2011https://conductscience.org/library/papers/21304530PubMed
527022975The Roles of MDM2 and MDMX in Cancer.Annu Rev Pathol2016https://conductscience.org/library/papers/27022975PubMed
626421824Urinary tract cancer survival in Europe 1999-2007: Results of the population-based study EUROCARE-5.Eur J Cancer2015https://conductscience.org/library/papers/26421824PubMed
728042869Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin β1 Signaling Pathways in Bladder Carcinoma.Int J Mol Sci2016https://conductscience.org/library/papers/28042869PubMed
825670033A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer.Endocr Relat Cancer2015https://conductscience.org/library/papers/25670033PubMed
932360052European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.Eur Urol2021https://conductscience.org/library/papers/32360052PubMed
1031513891miR-1307-3p overexpression inhibits cell proliferation and promotes cell apoptosis by targeting ISM1 in colon cancer.Mol Cell Probes2019https://conductscience.org/library/papers/31513891PubMed
1130207593Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin2018https://conductscience.org/library/papers/30207593PubMed
1214744438MicroRNAs: genomics, biogenesis, mechanism, and function.Cell2004https://conductscience.org/library/papers/14744438PubMed
1327375033Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.Eur Urol2017https://conductscience.org/library/papers/27375033PubMed
1428440444miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.Int J Oncol2017https://conductscience.org/library/papers/28440444PubMed
1519219610The present and future burden of urinary bladder cancer in the world.World J Urol2009https://conductscience.org/library/papers/19219610PubMed
1622265971MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulating GLUT3 expression.FEBS Lett2012https://conductscience.org/library/papers/22265971PubMed
1729311926Targeting the NFAT1-MDM2-MDMX Network Inhibits the Proliferation and Invasion of Prostate Cancer Cells, Independent of p53 and Androgen.Front Pharmacol2017https://conductscience.org/library/papers/29311926PubMed
1829117157Bladder cancer: 4 big questions.Nature2017https://conductscience.org/library/papers/29117157PubMed
1927698952Epigallocatechin-3-gallate Attenuates Renal Damage by Suppressing Oxidative Stress in Diabetic db/db Mice.Oxid Med Cell Longev2016https://conductscience.org/library/papers/27698952PubMed
2028401709The role of microRNA-93 regulating angiopoietin2 in the formation of malignant pleural effusion.Cancer Med2017https://conductscience.org/library/papers/28401709PubMed

See all 30 referencesDownload CSV of references

Cited by7

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42106777miR-1307-5p mediates endothelial dysfunction and inflammation induced by acute coronary syndrome by targeting PIM3.J Cardiothorac Surg2026https://conductscience.org/library/papers/42106777PubMed
41827493Profiling miRNA in Systemic Lupus Erythematosus Patients Adhering to a Mediterranean Diet: An Interventional Pilot Study.J Clin Med2026https://conductscience.org/library/papers/41827493PubMed
41750312Tyrosine-Peptide Analog Modulates Extracellular Vesicles miRNAs Cargo from Mesenchymal Stem/Stromal and Cancer Cells to Drive Immunoregeneration and Tumor Suppression.Biomolecules2026https://conductscience.org/library/papers/41750312PubMed
41009639Comprehensive Profiling Identifies Circulating microRNA Dysregulation in Vietnamese Patients with Heart Failure.Int J Mol Sci2025https://conductscience.org/library/papers/41009639PubMed
39883227Natural compounds as modulators of miRNAs: a new frontier in bladder cancer treatment.Med Oncol2025https://conductscience.org/library/papers/39883227PubMed
39744099Therapeutic Potential of Feline Adipose-Derived Stem Cell Exosomes in the Treatment of Feline Idiopathic Cystitis: A Characterization and Functional Analysis of miRNA Content.Nanotheranostics2025https://conductscience.org/library/papers/39744099PubMed
39006253Neurofibromin 2 modulates Mammalian Ste2-like kinases1/2 and large tumor suppressor gene1 expression in A549 lung cancer cell line.Am J Transl Res2024https://conductscience.org/library/papers/39006253PubMed

Download CSV of cited by

Genes16

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35778656

GET https://conductscience.org/api/papers/v1/35778656/references?page=2